BiomX Inc.
PHGE
$4.56
$0.051.11%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.37M | 14.21M | 14.48M | 13.91M | 11.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.24M | 34.23M | 36.39M | 34.68M | 31.44M |
| Operating Income | -32.24M | -34.23M | -36.39M | -34.68M | -31.44M |
| Income Before Tax | -37.37M | -18.56M | -8.05M | -17.71M | -8.69M |
| Income Tax Expenses | 9.00K | 6.00K | 9.00K | 13.00K | 11.00K |
| Earnings from Continuing Operations | -37.38 | -18.57 | -8.06 | -17.73 | -8.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.38M | -18.57M | -8.06M | -17.73M | -8.71M |
| EBIT | -32.24M | -34.23M | -36.39M | -34.68M | -31.44M |
| EBITDA | -29.55M | -32.46M | -34.58M | -32.87M | -30.34M |
| EPS Basic | -30.62 | -19.19 | -1.01 | -36.82 | -38.89 |
| Normalized Basic EPS | -13.82 | -2.77 | 3.84 | -23.83 | -30.44 |
| EPS Diluted | -32.36 | -20.93 | -51.61 | -87.43 | -87.79 |
| Normalized Diluted EPS | -13.82 | -2.77 | 1.59 | -26.07 | -32.68 |
| Average Basic Shares Outstanding | 5.48M | 4.69M | 3.42M | 2.53M | 1.89M |
| Average Diluted Shares Outstanding | 5.48M | 4.69M | 3.83M | 2.94M | 2.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |